Xanthus Pharmaceuticals
Online search and redirects.
Launch date
Market cap
-
Enterprise valuation
€91—136m (Dealroom.co estimates Dec 2006.)
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$20.4m | Series A | ||
$30.8m | Series B | ||
$25.0m | Series B | ||
N/A | £25.0m | Acquisition | |
Total Funding | €69.3m |